Morgan Stanley analyst Michael Infante raised the firm’s price target on Corpay (CPAY) to $390 from $379 and keeps an Overweight rating on the shares. As synergy realization and expense rationalization continue, the firm has “even more confidence in durable double-digit organic top-line growth and even faster cash EPS growth,” the analyst tells investors in a post-earnings note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CPAY:
- Corpay price target raised to $390 from $350 at JPMorgan
- Corpay: Resilient Double-Digit Growth, Fading Stablecoin Overhang, and Undervalued Cash EPS Drive Upgraded $390 Target
- Corpay: Differentiated Fintech Leader Poised for Durable Growth and Superior Free Cash Flow
- Closing Bell Movers: Qualcomm slumps 9% on earnings and soft outlook
- Corpay posts strong Q4 results and 2026 growth outlook
